Table 3 Treatment agents used in each of the three phenotypes of optic neuritis.
From: Clinical characteristics of optic neuritis phenotypes in a 3-year follow-up Chinese cohort
MOG-ON (n = 57) | AQP4-ON (n = 98) | seronegative-ON (n = 125) | |
|---|---|---|---|
Prednisone | 5 | 12 | 3 |
Mycophenolate mofetil | 14 | 6 | 2 |
Azathioprine | 3 | 16 | 0 |
Cyclosporine | 0 | 10 | 0 |
Methotrexate | 0 | 2 | 1 |
Cyclophosphamide | 0 | 1 | 1 |
Fingolimod | 0 | 0 | 1 |
Teriflunomide | 0 | 0 | 1 |
Interferon-β | 0 | 0 | 2 |
Rituximab | 2 | 13 | 2 |
Immunoglobulin | 3 | 4 | 2 |
PE or IA | 2 | 7 | 4 |
withdrawal medication | 36 | 41 | 112 |
